lan.png
EN
search.png
{$ImageUrl,alt}
Blog
home.png Home>Blog>Litchlab — Your Reliable CDMO Partner for API Development and GMP Manufacturing

Litchlab — Your Reliable CDMO Partner for API Development and GMP Manufacturing

As an integrated CDMO with proven expertise in drug delivery systems, Litchlab also provides end-to-end services for Active Pharmaceutical Ingredient (API) development and manufacturing, helping global pharmaceutical partners bridge the gap from early-stage discovery to commercial supply.

416.jpg

API Development Expertise at Litchlab

1️⃣ Process Development & Scale-Up

  • Route scouting and synthetic pathway optimization for complex small molecules.

  • Quality by Design (QbD)-driven process development with risk assessment and parameter control.

  • Comprehensive impurity profiling and control strategies (ICH Q3A/Q3B compliant).

  • Design of Experiments (DoE) for process robustness and scalability.

  • Patent-avoiding synthetic routes for freedom to operate (FTO) assurance.


2️⃣ Analytical Method Development & Validation

  • Structural characterization: NMR (1D/2D), HR-MS, FTIR, UV-Vis spectroscopy.

  • Purity and impurity quantification via HPLC/UPLC, GC, IC.

  • Residual solvent and elemental impurity analysis (GC-HS, ICP-MS).

  • Stability studies (accelerated, long-term, photostability) under ICH Q1A guidelines.

  • Full analytical validation to support IND, ANDA, and NDA submissions (FDA, EMA, NMPA compliant).


3️⃣ GMP Manufacturing Services

  • Scale flexibility from gram-scale synthesis to kilogram-scale pilot batches and commercial production.

  • cGMP-compliant facilities, adhering to FDA, EMA, and NMPA regulatory expectations.

  • Dedicated DMF documentation preparation and regulatory support.

  • Robust quality system including deviation investigation, change control, and batch traceability.


⚙️ API Portfolio Highlights

API TypeTechnical FeaturesTherapeutic Application
Small Molecule APIsHigh-purity, impurity-controlled synthesisGeneric drugs / NCEs
Peptide APIsSolid-phase and liquid-phase synthesis, site-specific modificationsInjectable formulations / biologics
Nucleic Acid APIs (siRNA, mRNA)High-fidelity oligonucleotide synthesis and chemical modificationsGene therapy / Vaccines
ADC Payload APIsCustom linker-payload synthesis and purity profilingAntibody-drug conjugates (ADC)


🏆 Why Partner with Litchlab?

✔️ Tailored process development from lab scale to GMP-grade production.
✔️ Comprehensive analytical support across the entire API lifecycle.
✔️ Scalable manufacturing solutions from clinical to commercial supply.
✔️ Seamless collaboration with formulation development for lipid-based and microsphere delivery systems.
✔️ Extensive regulatory experience with global DMF preparation and submission.

📧 Contact: RD1@litchlab.com
📩 Learn more or inquire about a project: www.litchlab.com